Lacosamide
NDC 16714-552, Lacosamide, tablet, from NorthStar RxLLC.
- Product NDC
- 16714-552
- Status
- Listed
- Labeler
- NorthStar RxLLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA208308
- DEA schedule
- CV
curl https://api.healthcare.dev/v1/drugs/ndc/16714-552 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LACOSAMIDE200 mg/1
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 16714-552-01 | 16714055201 | 60 TABLET in 1 BOTTLE (16714-552-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/9dffda6c-9e44-478f-9e02-9da3ab4c50e1NADAC price for package 16714055201
GET /v1/drugs/nadac/16714055201
Use it
Look up 16714-552 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/16714-552 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 16714-552. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.